Now that the Food and Drug Administration is using AI to “speed up” the drug approval process, it seems the sky’s the limit on what wacko products are approved for commercial sale. The crypto company Tharimmune Inc, for example, was recently given “positive feedback” from the FDA on a drug called Nalmefene, clinically labeled TH104. According to Filter, the drug is being developed as a longer-lasting alternative to Nalaxone, an opioid-reversal agent which typical wears off in 20 to 90 minutes. Per Filter, the drug isn’t meant for reversing overdoses in people with substance abuse disorders, but in first responders and military members who might come in contact with them. It also increases the risk of fatal overdose in drug users.